Oxytocin receptor agonist reduces perinatal brain damage by targeting microglia
Publié dansGlia, vol. 67, no. 2, p. 345-359
Date de publication2019
Résumé
Mots-clés
- Animals
- Animals, Genetically Modified
- Animals, Newborn
- Brain/pathology
- Brain Injuries/chemically induced/drug therapy/pathology
- Cells, Cultured
- Computational Biology
- Diet, Protein-Restricted/adverse effects
- Disease Models, Animal
- Female
- Green Fluorescent Proteins/genetics/metabolism
- Interleukin-1beta
- Lipopolysaccharides/toxicity
- Microglia/drug effects
- Oxytocics/therapeutic use
- Oxytocin/analogs & derivatives/therapeutic use
- Peptide Fragments
- Pregnancy
- Prenatal Exposure Delayed Effects/chemically induced/physiopathology
- RNA, Messenger/metabolism
- Receptors, Oxytocin/metabolism
- Zebrafish
- Microglia
- Myelination
- Neuroprotection
- Oxytocin
- Perinatal stress
Structure d'affiliation
Groupe de recherche
Financement
- European Commission - A new neuroimaging modality: from bench to bedside [339244]
Citation (format ISO)
MAIRESSE, Jérôme et al. Oxytocin receptor agonist reduces perinatal brain damage by targeting microglia. In: Glia, 2019, vol. 67, n° 2, p. 345–359. doi: 10.1002/glia.23546
Fichiers principaux (1)
Article (Published version)
![accessLevelRestricted](assets/images/access-level-restricted.png)
Identifiants
- PID : unige:137446
- DOI : 10.1002/glia.23546
- PMID : 30506969
ISSN du journal0894-1491